MedPath

Modified Antibiotic Susceptibility Testing

Not Applicable
Conditions
Health Condition 1: A415- Sepsis due to other Gram-negativeorganisms
Registration Number
CTRI/2020/12/029794
Lead Sponsor
Antibiotic Resistance Leadership Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Positive blood culture with Gram stain showing GNB identified during local laboratory business hours

Exclusion Criteria

Positive blood culture for GNB at the same institution within prior 7 days (if known at the time of randomization), Deceased at the time of randomization, GNB plus Gram-positive bacterium, Gram-negative coccus, and/or yeast detected on Gram stain

•Previous enrollment in this study

•Not hospitalized

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We anticipate that patients whose blood cultures are characterized using DISK will have faster time to effective antibiotic therapy and better clinical outcomes than patients whose blood cultures are characterized using standard of care methods.Timepoint: one week of admission, date of discharge OR upto 30 days of hospitalisation
Secondary Outcome Measures
NameTimeMethod
We anticipate that patients whose blood cultures are characterized using DISK will have better antibiotic utilization and lesser irrational antibiotic therapy than patients whose blood cultures are characterized using standard of care methods.Timepoint: one week of admission, date of discharge OR upto 30 days of hospitalisation
© Copyright 2025. All Rights Reserved by MedPath